Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione (Q42681968)

4 November 2017

title

Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione (English)

1 reference

4 November 2017

R M LoPachin

1

1 reference

4 November 2017

J F Ross

2

1 reference

4 November 2017

M L Reid

3

1 reference

4 November 2017

S Das

4

1 reference

4 November 2017

S Mansukhani

5

1 reference

4 November 2017

E J Lehning

6

1 reference

4 November 2017

publication date

1 May 2002

1 reference

4 November 2017

1 reference

4 November 2017

volume

23

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

95-110

1 reference

Metabolism, toxicokinetics and hemoglobin adduct formation in rats following subacute and subchronic acrylamide dosing

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

gamma-diketone peripheral neuropathy. II. Neurofilament subunit content

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

The impact of dose rate on the neurotoxicity of acrylamide: the interaction of administered dose, target tissue concentrations, tissue damage, and functional effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

A simple, sensitive, and objective method for early assessment of acrylamide neuropathy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Pathogenetic studies of hexane and carbon disulfide neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Clinical and electrophysiological characteristics of the experimental neuropathy caused by p-bromophenylacetylurea

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Biochemical and morphologic characterization of acrylamide peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Mechanism of calcium entry during axon injury and degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Nerve terminals as the primary site of acrylamide action: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

The Mechanisms of Acrylamide Axonopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Comparison of chlordimeform and carbaryl using a functional observational battery.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Comparison of subchronic neurotoxicity of 2-hydroxyethyl acrylate and acrylamide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Gamma-diketone peripheral neuropathy III. Neurofilament gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Pharmacological subtraction of the sensory controls over grasping in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Quantification of the hindlimb extensor thrust response in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

A neurotoxicity screening battery for use in safety evaluation: Effects of acrylamide and 3?,3?-iminodipropionitrile

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Neurotoxicity of acrylamide and 2,5-hexanedione in rats evaluated using a functional observational battery and pathological examination

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Characterization of carbon disulfide neurotoxicity in C57BL6 mice: behavioral, morphologic, and molecular effects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Preliminary neurological evaluation of generalized weakness in zinc pyrithione-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

Clinical and experimental studies of distal axonopathy -- a frequent form of brain and nerve damage produced by environmental chemical hazards

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

The enlarging view of hexacarbon neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

The effects of acrylamide given acutely or in repeated doses on fore- and hindlimb function of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900003-7

7 January 2021

10.1016/S0161-813X(02)00003-7

Identifiers

DOI

1 reference

4 November 2017

1 reference